TSX News -
Diversified Royalty Corp. Announces September 2024 Cash Dividend
VANCOUVER, British Columbia, Sept. 03, 2024 (GLOBE NEWSWIRE) — Diversified Royalty Corp. (TSX: DIV and DIV.DB.A) (the “Corporation” or “DIV”) is […]
TSX News -
Change to the Board of Directors of Colabor Group Inc.
SAINT-BRUNO-DE-MONTARVILLE, Quebec, Sept. 03, 2024 (GLOBE NEWSWIRE) — Colabor Group Inc. (TSX: GCL) (“Colabor” or the “Company”) announces that Mr. […]
TSX News -
Petrus Resources Declares Monthly Dividend for September 2024
CALGARY, Alberta, Sept. 03, 2024 (GLOBE NEWSWIRE) — Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to […]
TransAlta Announces Dividend Rates on Series G Preferred Shares and Series H Preferred Shares
CALGARY, Alberta, Sept. 03, 2024 (GLOBE NEWSWIRE) — Further to the news release of TransAlta Corporation (“TransAlta” or the “Company”) […]
TSX News -
Element Announces Executive Transition: Celebrating the Leadership of Frank Ruperto and Welcoming Heath Valkenburg as New CFO
TORONTO, Sept. 03, 2024 (GLOBE NEWSWIRE) — Element Fleet Management Corp. (TSX:EFN) (“Element” or the “Company”), the largest publicly traded, […]
Healthcare Realty Trust Expands Nuveen JV, Bringing Total Year-to-Date Proceeds to Approximately $700 Million
NASHVILLE, Tenn., Sept. 03, 2024 (GLOBE NEWSWIRE) — Healthcare Realty Trust Incorporated (NYSE:HR) completed the contribution of eight properties for […]
ARCPOINT PROVIDES CORPORATE UPDATE ON BENEFITS OF CRESSO TRANSACTION
Greenville, South Carolina, Sept. 03, 2024 (GLOBE NEWSWIRE) — ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) is pleased to […]
Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
LEXINGTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences […]
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to October 3, 2024
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) — Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”), a special […]
Cellectis Presents Pre-Clinical Evidence of MUC1 CAR T-cells Reducing Triple-Negative Breast Cancer While Preserving Safety
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology […]
